Current studies suggest that abnormalities in B cell development and differentiation, as well as dysregulation of the B cell receptor (BCR) signaling pathway, are involved in the pathogenesis and immunological manifestations of SLE [3–5]. This evidence concerns the gene BCR and systemic lupus erythematosus.